| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 31.770 | 46.271 | 32.706 | 42.666 | 45.934 | 46.786 | 53.616 |
| Total Income - EUR | - | - | - | 31.771 | 46.280 | 32.720 | 42.666 | 45.934 | 46.786 | 53.616 |
| Total Expenses - EUR | - | - | - | 13.109 | 20.722 | 15.239 | 15.607 | 17.008 | 23.073 | 23.250 |
| Gross Profit/Loss - EUR | - | - | - | 18.662 | 25.559 | 17.482 | 27.059 | 28.926 | 23.713 | 30.365 |
| Net Profit/Loss - EUR | - | - | - | 18.344 | 25.096 | 16.728 | 25.784 | 27.547 | 23.243 | 28.757 |
| Employees | - | - | - | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nicoderma Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 17.628 | 13.181 | 8.952 | 4.863 | 1.683 | 464 | 221 |
| Current Assets | - | - | - | 20.348 | 31.988 | 44.878 | 37.866 | 33.187 | 34.092 | 30.078 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 8.609 | 3.762 | 2.714 | 467 | 22.465 | 19.444 | 18.133 |
| Cash | - | - | - | 11.738 | 28.226 | 42.164 | 37.398 | 10.722 | 14.648 | 11.944 |
| Shareholders Funds | - | - | - | 18.387 | 43.127 | 52.022 | 42.190 | 27.596 | 23.292 | 28.805 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 19.589 | 2.042 | 1.809 | 539 | 7.275 | 11.264 | 1.493 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicoderma Consult S.r.l.